netFormulary
 Report : A-Z CDF items in Formulary 17/06/2021 21:22:25
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios
08.01.05 Formulary Cancer Drugs Fund Acalabrutinib 
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.02 Non Formulary Cancer Drugs Fund Autologous anti-CD19-transduced CD3+ cells Tecartus
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis
08.01.03 Formulary Cancer Drugs Fund Clofarabine 
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx ,
Myocet
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi
08.01.05 Formulary Cancer Drugs Fund Entrectinib 
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.02 Formulary Cancer Drugs Fund Isatuximab Sarclisa
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro
08.01.05 Formulary Cancer Drugs Fund Larotrectinib Vitrakvi
08.02.04 Formulary Cancer Drugs Fund Lenalidomide  Revlimid
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance
08.02.04 Formulary Cancer Drugs Fund Niraparib Zejula
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza
08.02.04 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.02.04 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.03.04.02 Non Formulary Cancer Drugs Fund Radium-223 dichloride 
08.01.05 Formulary Cancer Drugs Fund Ribociclib Kisqali
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Formulary Cancer Drugs Fund Trastuzumab deruxtecan Enhertu
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
Shropshire and Telford Local Health Economy